Skip to main content
Log in

Comparative study of autologous, total E and ‘active’ E-rosette-forming T lymphocytes in untreated Hodgkin's disease

  • Original Articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

In order to evaluate the value of autologous rosettes, a marker for a T lymphocyte subpopulation, in the diagnosis of T lymphocyte defects, we compared the ability of T cells from untreated patients with Hodgkin's disease to form autologous, total E and ‘active’ E rosettes. While the mean percentage of total E and ‘active’ E rosettes was significantly decreased in the patients compared to normal controls (0.01<P<0.02), no difference was observed for autologous rosettes (0.6<P<0.7). Only two patients showed decreased ‘active’ E rosettes whilst eight had decreased total E rosettes. Individual data in the patients showed a wide dispersion of autologous rosettes with both high and low percentages whatever the relative number of the two other T cell markers. No correlation was observed between any of the three types of rosettes in the patients whereas autologous rosettes were clearly correlated with total E (0.01<P<0.02) but not with ‘active’ rosettes in normal controls. Neither autologous nor ‘active’ rosettes could be correlated with skin test results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Björkholm M (1978) Immunodeficiency in Hodgkin's disease and its relation to prognosis. Scand J Haematol (Suppl 33)

  2. Bobrove AM, Fuks Z, Strober S, Kaplan HS (1975) Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease. Cancer 36:169

    Google Scholar 

  3. Caraux J, Thierry C, Estève C, Flores G, Ladise R, Serrou B (1979) Human autologous rosettes. I. Mechanism of binding of autologous erythrocytes by T cells. Cell Immunol 45:36

    Google Scholar 

  4. Caraux J, Thierry C, Serrou B (1979) Human autologous rosettes; II. Prognostic significance of variations in autologous rosette forming cells in the peripheral blood of cancer patients. J Natl Cancer Inst 63:593

    Google Scholar 

  5. Charreire J, Bach JF (1974) Self and not self. Lancet 2:299

    Google Scholar 

  6. Dewar AE, Stuart AE, Parker AC, Wilson C (1974) Rosetting cells in auto-immune haemolytic anaemia. Lancet 2:519

    Google Scholar 

  7. Fudenberg HH, Wybran J, Robbins D (1975) T-rosette-forming cells, cellular immunity and cancer. N Engl J Med 292:475

    Google Scholar 

  8. Gluckman JC, Montambault P (1975) Spontaneous autorosette-forming cells in man. A marker for a subset population of T lymphocytes? Clin Exp Immunol 22:302

    Google Scholar 

  9. Kaplan J (1975) Human T lymphocytes form rosettes with autologous and allogeneic human red blood cells. Clin Immunol Immunopathol 3:471

    Google Scholar 

  10. Kniker WT, Anderson CT, Roumiantzeff M (1979) Multi-test system. Standardized approach to evaluation of delayed hypersensitivity and cell-mediated immunity. Ann Allergy 43:73

    Google Scholar 

  11. Lambermont M, Wybran J, Govaerts A (1977) Human autologous and allogeneic rosettes. J Immunol Methods 15:157

    Google Scholar 

  12. Lang JM, Bigel P, Oberling F, Mayer S (1977) Normal active rosette-forming cells in untreated patients with Hodgkin's disease. Biomedicine 27:322

    Google Scholar 

  13. Lang JM, Ruscher H, Hasselmann JP, Grandjean P, Bigel P, Mayer S (1980) Decreased autologous rosette-forming T lymphocytes in alcoholic cirrhosis. Absence of correlation with other T cell markers and with delayed cutaneous hypersensitivity. Int Arch Allergy Appl Immunol 61:337

    Google Scholar 

  14. Lang JM, Hasselmann JP, Roeslin N, Bigel P, Mayer S, Witz JP (1980) Comparative study of autologous and ‘active’ rosette-forming T lymphocytes in untreated patients with non metastatic squamous cell lung carcinoma. Cancer Immunol Immunother 8:45

    Google Scholar 

  15. Long JC (1979) The immunopathology of Hodgkin's disease. Clin Haematol 8:531

    Google Scholar 

  16. Lukes RJ, Butler JJ (1966) The pathology and nomenclature of Hodgkin's disease. Cancer Res 26:1063

    Google Scholar 

  17. Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P (1966) Report of the nomenclature committee. Cancer Res 26:1311

    Google Scholar 

  18. Sandilands GP, Gray K, Cooney A, Browning JD, Anderson JR (1975) Formation of auto-rosettes by peripheral blood lymphocytes. Clin Exp Immunol 22:493

    Google Scholar 

  19. Wybran J, Fudenberg HH (1973) Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections and other diseases. J Clin Invest 52:1026

    Google Scholar 

  20. Wybran J (1977) Various subpopulations of autologous T rosettes in cancer patients (abstract). Cancer Immunol Immunother 3 (Suppl) 3:S2

    Google Scholar 

  21. Yu DTY (1975) Lymphocyte subpopulations. Human red blood cell rosettes. Clin Exp Immunol 20:311

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lang, JM., Hasselmann, JP., Giron, C. et al. Comparative study of autologous, total E and ‘active’ E-rosette-forming T lymphocytes in untreated Hodgkin's disease. Cancer Immunol Immunother 10, 239–242 (1981). https://doi.org/10.1007/BF00205525

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00205525

Keywords

Navigation